Sing Fai Leung

TL;DR: Results suggest that quantitative analysis of plasma EBV DNA may be a useful clinical and research tool in the screening and monitoring of NPC patients.

TL;DR: IMRT is superior to 2DRT in preserving parotid function and results in less severe delayed xerostomia in the treatment of early-stage NPC, which reflects the need to enhance protection of other salivary glands.

TL;DR: Chemotherapy led to a small, but significant, benefit for overall survival and event-free survival when chemotherapy was administered concomitantly with RT.

TL;DR: The authors' experience of using IMRT in the primary treatment of NPC showed a very high rate of locoregional control and favorable toxicity profile, and it was found that dose escalation above 66 Gy of IMRT-based therapy was a significant determinant of progression- free survival and distant metastasis-free survival for advanced T-stage tumors.

TL;DR: Analysis of EBV DNA in plasma samples was useful in screening for early asymptomatic nasopharyngeal carcinoma and outcomes were better in participants who were identified by screening than in those in a historical cohort.